Drug Database
Back to search

Belgium· BE-AMP-SAM256182-00

Moxonidine Viatris 0.2 mg

A moxonidine product containing moxonidine, registered in Belgium by Viatris GX. The same ATC class is registered in 13 of our 19 countries.

ATC C02AC05

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedMoxonidine Viatris 0.2 mgATCC02AC05REGISTER NO.BE-AMP-SAM256182-00PACKS LISTED3CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about moxonidineAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Moxonidine is registered in 13 of 19 countries.

Countries holding a registration under ATC C02AC05 (moxonidine), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 8 of them publish a price we can compare per daily dose
Search moxonidine products by name

Moxonidine · ATC C02AC05

13 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of moxonidine costs, country by country.

Normalised to the WHO defined daily dose (0.3 mg), the median price runs from $0.19 in France to $0.70 in Switzerland — a ×3.7 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Moxonidine · price per daily dose (0.3 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.70
  • IT Italy$0.35
  • FR France$0.19
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Moxonidine
Manufacturer
Viatris GX
Country
Belgium (BE)
ATC code
C02AC05
ATC class
Moxonidine
Defined daily dose
0.3 mg, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 3

2 priced
  • be_apb
    0777649
  • be_apb
    3000882
    EUR 9.7
  • be_apb
    3012176
    EUR 17.49

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Moxonidine in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All moxonidine products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

  • Austria · Moxonibene, Moxonidin Stada
  • Bulgaria · Moxotens, Moксотенс
  • Cyprus · Physiotens, Tarwoxin
  • Czechia · Cynt, Moxonidin Actavis
  • Germany · Moxogamma, Moxonidin 1 A Pharma
  • Denmark · Moxonat, Moxonidin Teva
  • Estonia · Moxogamma, Moxonidin Actavis
  • Spain · Moxon
  • Finland · Moxonidin Ratiopharm, Moxonidin Stada
  • France · Moxonidine Biogaran, Moxonidine Eg
  • United Kingdom (Northern Ireland) · Moxonidine, Moxonidine Generics [uk]
  • Greece · Cynt, Fisiotens
  • Croatia · Cynt, Moksonidin Belupo
  • Hungary · Moxogamma, Moxonidin Ratiopharm
  • Italy · Fisiotens, Moxonidina Eg
  • Lithuania · Moxogamma, Moxonidin Hexal
  • Luxembourg · Moxonidine Eg, Moxonidine Viatris
  • Latvia · Moxogamma, Moxonidin Actavis
  • Malta · Physiotens
  • Netherlands · Moxamar, Moxonidine Pch
  • Norway · Moxonidin Actavis, Physiotens
  • Poland · Physiotens
  • Portugal · Moxon
  • Romania · Physiotens
  • Sweden · Moxonidin Actavis, Moxonidin Stada
  • Slovenia · Filmsko Obložene Tablete, Moxogamma, Moxogamma
  • Slovakia · Moxogamma, Moxonidin Ratiopharm

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/60696e1d-bc76-4376-bdd3-e6556ffc0687
GET /v1/drugs/60696e1d-bc76-4376-bdd3-e6556ffc0687?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Moxonidine Viatris 0.2 mg",
  "name_fr": "Moxonidine Viatris 0.2 mg",
  "name_nl": "Moxonidine Viatris 0.2 mg",
  "amp_code": "SAM256182-00",
  "strengths": [
    "0.2000",
    "0.2000",
    "94.5000"
  ],
  "pack_count": 7,
  "substances": [
    "Moxonidine",
    "Lactose Monohydrate"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Moxonidine",
  "authorisation_numbers": [
    "BE256182"
  ]
}
API referenceMCP serverPlans

See everything about moxonidine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console